BiogenBIIB 
$197.53-0.34%24h
-0.34%24h
Global rank648
Market cap$28.58B
Change 7d0.14%
YTD Performance-23.31%
SP500 benchmarkUnderperform
P/E24.78
P/S2.91
Revenue$9.84B
Earnings$1.16B
Dividend yield-
Main Sector
Healthcare
Category
Biogen BIIB Total Debt
BIIB Total Debt in 2022: $7.19B
According to Biogen latest financial reports the total debt is $7.19B, an increase of 8.68% to 2022. At the end of 2022 company had $6.61B total debt. This figure represents the debts and financial obligations that Biogen combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Biogen BIIB Total Debt History from 2023 to 2022
-
Value:-
BIIB Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $7.19B | 8.68% |
| 2022 | $6.61B | 0.15% |
| 2021 | $6.60B | -15.63% |
| 2020 | $7.83B | 60.69% |
| 2019 | $4.87B | -17.94% |
| 2018 | $5.94B | - |
View the Top Total Debt Stocks 
